The 29-year-old from west London rejected her council's most recent temporary accommodation offer "an hour away" from her children's school.
Separate government figures from January to March gave a fuller breakdown showing many of those who did leave voluntarily did so without government assistance or even its knowledge at the time,This is despite repeated claims from ministers that the government has "removed" or even "deported" this many people.
The Home Office says all returns outcomes are the result of collective efforts by the department.The US has dismantled large parts of a camp built to house migrants at the Guantanamo Bay Naval Base, satellite images reviewed by BBC Verify show.President Donald Trump ordered the existing facility in Cuba be expanded to hold 30,000 migrants shortly after taking office in January. However, only a small number were ever actually held at the base.
The Pentagon spent around $38m (£28.7m) on deportation and detention operations at Guantanamo Bay in the first month of operations this year alone, a Department of Defense official said.But new images now show that around two-thirds of the roughly 260 tents installed as part of the operation had been removed as of 16 April.
When asked about the removal of the tents, a US defence official said: "This force adjustment represents a deliberate and efficient use of resources - not a reduction in readiness."
The camp began construction just a day after President Trump announced the plan, with tents going up between 30 January and 12 February. Visible construction continued until 8 March, with scattered temporary structures appearing on satellite imagery."The way I cope with this is by thinking about today and today is a good day."
Ms Buchan is among thousands in the UK and millions worldwide who could benefit from the drug."I think I'm really lucky because I've got the most supportive husband, children and their partners and extended family and wonderful friends.
"What this drug can do for me is allow me to see my son's wedding next year and to look into the future."Despite its approval for use globally by the US Food and Drug Administration (FDA) in 2023, capivasertib only became available to patients via the NHS in England and Wales this year.